Search Results - "Niland, K."

A phase Ia/IIb trial of the CXCR4 inhibitor X4P-001 and nivolumab for advanced renal cell carcinoma (RCC) that is unresponsive to nivolumab monotherapy by Choueiri, T.K., Atkins, M.B., Rose, T.L., Alter, R.S., Tsiroyannis, E., Niland, K., Wang, Y., Parasuraman, S., Gan, L., McDermott, D.F.

Get full text

Effects of food on the pharmacokinetics of ponatinib in healthy subjects by Narasimhan, N. I., Dorer, D. J., Niland, K., Haluska, F., Sonnichsen, Daryl

“…Summary What is known and objective Ponatinib is a potent oral tyrosine kinase inhibitor with activity against BCR‐ABL, the primary driver of chronic myeloid…”
Get full text

NUTRITION SERVICES PROGRAM PARTICIPATION AND THE DIET QUALITY OF OLDER ADULTS by Gearan, E, Mabli, J, Niland, K

“…Congregate and home-delivered meals provided through the Title III-C Nutrition Services Program (NSP) can be an important source of nutrition for older adults…”
Get full text

1134PDA phase Ia/IIb trial of the CXCR4 inhibitor X4P-001 and nivolumab for advanced renal cell carcinoma (RCC) that is unresponsive to nivolumab monotherapy by Choueiri, T K, Atkins, M B, Rose, T L, Alter, R S, Tsiroyannis, E, Niland, K, Wang, Y, Parasuraman, S, Gan, L, McDermott, D F

Get full text